PepGen Inc. (PEPG)
Develops experimental drug treatments for rare muscle and nerve diseases.
$1.83-0.04%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+38.6%
The outlook
PEPG is trading near its 52-week low at $1.83, with analyst sentiment currently leaning bearish. The stock sits well below its moving averages, though the average analyst price target sits roughly 460% above the current price, reflecting significant disagreement about fair value.
What’s behind the score
Price trendMixed vs its moving averages
52-week range12% of the way from its 52-week low to high
Price targetAvg target +460% vs current price
Analyst price target
~12-month · 8 analysts$10.25average target+460.1% vs now
Now $1.83
Low $3.00High $20.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$126.6M
52-wk high
$7.80
52-wk low
$1.01
50-day avg
$1.76
200-day avg
$3.93
Trailing P/E
—